Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
5.09
-0.18 (-3.42%)
Aug 24, 2026, 3:04 PM CST

SHE:300006 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,085926.061,072836.44846.29559.43
Cash & Short-Term Investments
1,085926.061,072836.44846.29559.43
Cash Growth
10.69%-13.62%28.18%-1.16%51.28%2.67%
Accounts Receivable
203.16252.92286.67339.21348.39445.38
Other Receivables
185.46149.15166.75268.73312.52539.13
Receivables
388.62402.08453.42607.94660.9984.51
Inventory
177.53161.33201.7171202.4157.77
Prepaid Expenses
-7.2911.33.582.664.5
Other Current Assets
40.7224.5831.5727.2133.2320.78
Total Current Assets
1,6921,5211,7701,6461,7451,727
Property, Plant & Equipment
244.11252.17274.92286.97339.92392.49
Long-Term Investments
374.85384.12378.28519.68522.71481.36
Goodwill
44.9544.9544.9532.9432.9432.94
Other Intangible Assets
129.77131.18181.83189.3184.11116.36
Long-Term Accounts Receivable
---34.0632.41-
Long-Term Deferred Tax Assets
154.8152.39128.24132.35116.58104.62
Long-Term Deferred Charges
67.6855.5240.3627.2463.3762.53
Other Long-Term Assets
23.8933.0437.1322.1517.649.47
Total Assets
2,7322,5752,8562,8913,0552,927

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
114.3193.4865.6237.949.6334.26
Accrued Expenses
23.3699.58110.77107.55110.39109.24
Short-Term Debt
304.31179.42242.91113.5121.5130
Current Portion of Long-Term Debt
82.66131.8102.752458-
Current Portion of Leases
-3.613.654.2630.255.41
Current Income Taxes Payable
4.130.861.312.127.877.03
Current Unearned Revenue
15.713.2113.7917.8524.0413.07
Other Current Liabilities
307.71206.54260.8255.09299.51317.8
Total Current Liabilities
852.17728.49801.61562.27701.14666.8
Long-Term Debt
105.8157.2141.45126.5149-
Long-Term Leases
0.71.463.832.536.5733.9
Long-Term Unearned Revenue
4.614.456.296.399.0412.26
Long-Term Deferred Tax Liabilities
18.9819.0519.2919.264.471.68
Other Long-Term Liabilities
---51.76--
Total Liabilities
982.26810.65972.47768.71870.22714.65

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
1,0561,0561,0561,0561,0561,056
Additional Paid-In Capital
1,5051,5071,4831,4831,4751,459
Retained Earnings
-766.47-750.67-501.33-414.9-406.22-358.52
Comprehensive Income & Other
-63.53-56.23-162.53-43.77--
Total Common Equity
1,7311,7561,8752,0812,1242,156
Minority Interest
18.28.188.0441.5160.5255.78
Shareholders' Equity
1,7491,7641,8832,1222,1852,212
Total Liabilities & Equity
2,7322,5752,8562,8913,0552,927

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
493.48373.48494.59270.79365.27219.32
Net Cash (Debt)
591.22552.58577.51565.65481.02340.11
Net Cash Growth
5.44%-4.32%2.10%17.59%41.43%-
Net Cash Per Share
0.560.520.550.540.460.34
Filing Date Shares Outstanding
1,0521,0561,0561,0561,0561,056
Total Common Shares Outstanding
1,0521,0561,0561,0561,0561,056
Working Capital
839.39792.85968.491,0841,0441,060
Book Value Per Share
1.641.661.781.972.012.04
Tangible Book Value
1,5561,5801,6491,8581,9072,007
Tangible Book Value Per Share
1.481.501.561.761.811.90
Buildings
-408.44411.75413.99412.67412.67
Machinery
-660.32652.83646.2674.06664.11
Construction In Progress
-0.6172.463.784.09